Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.285
+0.095 (2.98%)
Oct 21, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -79.83 | -20.6 | -63.69 | -65.77 | -60.51 | -110.09 |
Depreciation & Amortization | 0.01 | 0.08 | 0.19 | 0.17 | 0.16 | 0.11 |
Loss (Gain) From Sale of Assets | 0.18 | -87.27 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 3.72 | 74.16 |
Loss (Gain) From Sale of Investments | -2.25 | -1.53 | -1.3 | -3.14 | -1.22 | - |
Stock-Based Compensation | 8.82 | 9.87 | 10.84 | 11.95 | 9.64 | 2.11 |
Other Operating Activities | - | 0.07 | 0.46 | 0.52 | 0.38 | -0.95 |
Change in Accounts Receivable | - | -1 | -0.42 | -3.63 | -1.86 | 14.15 |
Change in Inventory | - | 0.17 | 1.12 | -3.27 | -1.86 | - |
Change in Accounts Payable | 2.19 | 3.92 | -9.77 | -0.13 | 3.22 | 8.29 |
Change in Other Net Operating Assets | 1.54 | -1.16 | 3.02 | 3.62 | -1.32 | -10.19 |
Operating Cash Flow | -69.35 | -97.43 | -59.55 | -59.66 | -49.64 | -22.42 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.55 | -1.65 | -3.97 | -0.44 | -0.05 |
Cash Acquisitions | - | - | - | - | - | 25.2 |
Divestitures | -0.07 | 101.29 | - | - | - | - |
Investment in Securities | -72.15 | -88.84 | 26.86 | 87.18 | -132.44 | - |
Investing Cash Flow | -72.22 | 11.89 | 25.2 | 83.21 | -132.89 | 25.15 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | 87.61 | 100.08 | 0.15 | 0.49 | 73.28 | 155.83 |
Preferred Dividends Paid | - | - | - | - | - | -4.41 |
Dividends Paid | - | - | - | - | - | -4.41 |
Other Financing Activities | -5.74 | -5.7 | -0.02 | -0.16 | -0.66 | -9.62 |
Financing Cash Flow | 81.87 | 94.38 | 0.13 | 0.33 | 72.62 | 141.8 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -59.7 | 8.83 | -34.22 | 23.87 | -109.91 | 144.53 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -69.35 | -97.99 | -61.2 | -63.64 | -50.08 | -22.47 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | -1371.38% | -235.55% | -261.29% | -329.15% | -2006.16% |
Free Cash Flow Per Share | -0.95 | -1.58 | -2.26 | -2.36 | -2.23 | -2.52 |
Levered Free Cash Flow | -43.61 | -53.65 | -38.69 | -37.7 | -29.52 | -15.23 |
Unlevered Free Cash Flow | -43.61 | -53.65 | -38.6 | -37.56 | -29.38 | -14.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | 0.21 | 0.23 | 0.23 | - |
Change in Working Capital | 3.73 | 1.93 | -6.05 | -3.4 | -1.82 | 12.25 |